|
1
|
Romero-Corral A, Montori VM, Somers VK,
Korinek J, Thomas RJ, Allison TG, Mookadam F and Lopez-Jimenez F:
Association of bodyweight with total mortality and with
cardiovascular events in coronary artery disease: A systematic
review of cohort studies. Lancet. 368:666–678. 2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang N, Song G, Yang Y, Yuan W and Qi M:
Inactivated Lactobacillus promotes protection against myocardial
ischemia-reperfusion injury through NF-κB pathway. Biosci Rep.
37(BSR20171025)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang J, Toan S and Zhou H: New insights
into the role of mitochondria in cardiac microvascular
ischemia/reperfusion injury. Angiogenesis. 23:299–314.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gao XM, Su Y, Moore S, Han LP, Kiriazis H,
Lu Q, Zhao WB, Ruze A, Fang BB, Duan MJ and Du XJ: Relaxin
mitigates microvascular damage and inflammation following cardiac
ischemia-reperfusion. Basic Res Cardiol. 114(30)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Beckman JS, Beckman TW, Chen J, Marshall
PA and Freeman BA: Apparent hydroxyl radical production by
peroxynitrite: Implications for endothelial injury from nitric
oxide and superoxide. Proc Natl Acad Sci USA. 87:1620–1624.
1990.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Loke KE, McConnell PI, Tuzman JM, Shesely
EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS and
Hintze TH: Endogenous endothelial nitric oxide synthase-derived
nitric oxide is a physiological regulator of myocardial oxygen
consumption. Circ Res. 84:840–845. 1999.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Radomski MW, Palmer RM and Moncada S:
Endogenous nitric oxide inhibits human platelet adhesion to
vascular endothelium. Lancet. 2:1057–1058. 1987.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Reardon CE, Kane-Gill SL, Smithburger PL
and Dasta JF: Sufentanil sublingual tablet: A new option for acute
pain management. Ann Pharmacother. 53:1220–1226. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kim DK, Yoon SH, Kim JY, Oh CH, Jung JK
and Kim J: Comparison of the effects of sufentanil and fentanyl
intravenous patient controlled analgesia after lumbar fusion. J
Korean Neurosurg Soc. 60:54–59. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ohnesorge H, Alpes A, Baron R and
Gierthmühlen J: Influence of intraoperative remifentanil and
sufentanil on sensory perception: A randomized trial. Curr Med Res
Opin. 32:1797–1805. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang Y, Teng X and Zhu J: Sufentanil
blunts the myocardial stress induced by tracheal intubation in
older adult patients with coronary heart disease better than
equipotent fentanyl. Ann Palliat Med. 9:3909–3914. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lemoine S, Zhu L, Massetti M, Gérard JL
and Hanouz JL: Continuous administration of remifentanil and
sufentanil induces cardioprotection in human myocardium, in vitro.
Acta Anaesthesiol Scand. 55:758–764. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Liu X, Jing G, Bai J and Yuan H: Effect of
sufentanil preconditioning on myocardial P-Akt expression in rats
during myocardial ischemia-reperfusion. Nan Fang Yi Ke Da Xue Xue
Bao. 34:335–340. 2014.PubMed/NCBI(In Chinese).
|
|
14
|
Wei J, Gou Z, Wen Y, Luo Q and Huang Z:
Marine compounds targeting the PI3K/Akt signaling pathway in cancer
therapy. Biomed Pharmacother. 129(110484)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li Y, Xia J, Jiang N, Xian Y, Ju H, Wei Y
and Zhang X: Corin protects H2O2-induced
apoptosis through PI3K/AKT and NF-κB pathway in cardiomyocytes.
Biomed Pharmacother. 97:594–599. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fruman DA, Chiu H, Hopkins BD, Bagrodia S,
Cantley LC and Abraham RT: The PI3K pathway in human disease. Cell.
170:605–635. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hay N: The Akt-mTOR tango and its
relevance to cancer. Cancer Cell. 8:179–183. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Chen E, Chen C, Niu Z, Gan L, Wang Q, Li
M, Cai X, Gao R, Katakam S, Chen H, et al: Poly(I:C)
preconditioning protects the heart against myocardial
ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent
pathway. Signal Transduct Target Ther. 5(216)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jacob B, Kloss N, Böhle S, Kirschberg J,
Zippelius T, Heinecke M, Matziolis G and Röhner E: Tranexamic acid
is toxic on human chondrocytes, in vitro. J Orthop. 20:1–5.
2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Qi K, Yang Y, Geng Y, Cui H, Li X, Jin C,
Chen G, Tian X and Meng X: Tongxinluo attenuates
oxygen-glucose-serum deprivation/restoration-induced endothelial
barrier breakdown via peroxisome proliferator activated
receptor-α/angiopoietin-like 4 pathway in high
glucose-incubated human cardiac microvascular endothelial cells.
Medicine (Baltimore). 99(e21821)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen QL, Gu EW, Zhang L, Cao YY, Zhu Y and
Fang WP: Diabetes mellitus abrogates the cardioprotection of
sufentanil against ischaemia/reperfusion injury by altering
glycogen synthase kinase-3β. Acta Anaesthesiol Scand.
57:236–242. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tao H, Nuo M and Min S: Sufentanil
protects the rat myocardium against ischemia-reperfusion injury via
activation of the ERK1/2 pathway. Cytotechnology. 70:169–176.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu Y, Gu EW, Zhu Y, Zhang L, Liu XQ and
Fang WP: Sufentanil limits the myocardial infarct size by
preservation of the phosphorylated connexin 43. Int
Immunopharmacol. 13:341–346. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yu H, Kalogeris T and Korthuis RJ:
Reactive species-induced microvascular dysfunction in
ischemia/reperfusion. Free Radic Biol Med. 135:182–197.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Müller-Werdan U, Prondzinsky R and Werdan
K: Effect of inflammatory mediators on cardiovascular function.
Curr Opin Crit Care. 22:453–463. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ito H: Etiology and clinical implications
of microvascular dysfunction in patients with acute myocardial
infarction. Int Heart J. 55:185–189. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ríos-Navarro C, Hueso L, Miñana G, Núñez
J, Ruiz-Saurí A, Sanz MJ, Cànoves J, Chorro FJ, Piqueras L and Bodí
V: Coronary serum obtained after myocardial infarction induces
angiogenesis and microvascular obstruction repair. Role of
hypoxia-inducible factor-1A. Rev Esp Cardiol (Engl Ed). 71:440–449.
2018.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
29
|
Zhu T, Yao Q, Wang W, Yao H and Chao J:
iNOS induces vascular endothelial cell migration and apoptosis via
autophagy in ischemia/reperfusion injury. Cell Physiol Biochem.
38:1575–1588. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Filep JG, Sirois MG, Foldes-Filep E,
Rousseau A, Plante GE, Fournier A, Yano M and Sirois P: Enhancement
by endothelin-1 of microvascular permeability via the activation of
ETA receptors. Br J Pharmacol. 109:880–886. 1993.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tornavaca O, Chia M, Dufton N, Almagro LO,
Conway DE, Randi AM, Schwartz MA, Matter K and Balda MS: ZO-1
controls endothelial adherens junctions, cell-cell tension,
angiogenesis, and barrier formation. J Cell Biol. 208:821–838.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Giannotta M, Trani M and Dejana E:
VE-cadherin and endothelial adherens junctions: Active guardians of
vascular integrity. Dev Cell. 26:441–454. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Xie L, Wu Y, Fan Z, Liu Y and Zeng J:
Astragalus polysaccharide protects human cardiac microvascular
endothelial cells from hypoxia/reoxygenation injury: The role of
PI3K/AKT, Bax/Bcl-2 and caspase-3. Mol Med Rep. 14:904–910.
2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xing X, Guo S, Zhang G, Liu Y, Bi S, Wang
X and Lu Q: miR-26a-5p protects against myocardial
ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT
signaling pathway. Braz J Med Biol Res. 53(e9106)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yu P, Ma S, Dai X and Cao F: Elabela
alleviates myocardial ischemia reperfusion-induced apoptosis,
fibrosis and mitochondrial dysfunction through PI3K/AKT signaling.
Am J Transl Res. 12:4467–4477. 2020.PubMed/NCBI
|
|
36
|
Wu QL, Shen T, Ma H and Wang JK:
Sufentanil postconditioning protects the myocardium from
ischemia-reperfusion via PI3K/Akt-GSK-3β pathway. J Surg
Res. 178:563–570. 2012.PubMed/NCBI View Article : Google Scholar
|
